CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Obesity, Diabetes, and Acute Coronary Syndrome: Differences Between Asians and Whites Genotype-Guided Strategy for Oral P2Y12 Inhibitors Translational Perspective on Epigenetics in Cardiovascular Disease Association Between Living in Food Deserts and Cardiovascular Risk Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia High-Risk Coronary Atherosclerosis Is It the Plaque Burden, the Calcium, the Lipid, or Something Else? Classification of Deaths in Cardiovascular Outcomes Trials Known Unknowns and Unknown Unknowns Future of Personalized Cardiovascular Medicine

ConsensusNovember 2018

JOURNAL:J Am Coll Cardiol. Article Link

2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways

Writing Committee, Sandeep RD, Brendan M et al. Keywords: ASCVD; cardiovascular risk reduction; diabetes; Expert Consensus; Decision Pathway; GLP-1RA; SGLT2 inhibitor; T2D

FULL TEXT PDF